|
US4058614A
(en)
|
1973-12-04 |
1977-11-15 |
Merck & Co., Inc. |
Substituted imidazole compounds and therapeutic compositions therewith
|
|
US4296122A
(en)
|
1975-07-09 |
1981-10-20 |
Merck & Co., Inc. |
2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids
|
|
DE2707268A1
(de)
|
1977-02-19 |
1978-08-31 |
Hoechst Ag |
Indol-3-carbaldehyd-oxime und verfahren zu ihrer herstellung
|
|
DE2707270A1
(de)
|
1977-02-19 |
1978-08-24 |
Hoechst Ag |
Pyrazolo-diazepine und verfahren zu ihrer herstellung
|
|
DE2707269A1
(de)
|
1977-02-19 |
1978-08-24 |
Hoechst Ag |
Heterocyclische stickstoffverbindungen und verfahren zu ihrer herstellung
|
|
DE2727802A1
(de)
|
1977-06-21 |
1979-04-19 |
Hoechst Ag |
Sulfamoyl-arylketone und verfahren zu ihrer herstellung
|
|
JPS5936919B2
(ja)
|
1978-10-14 |
1984-09-06 |
日本新薬株式会社 |
インド−ル誘導体
|
|
DE3112116A1
(de)
|
1981-03-27 |
1982-11-04 |
Mundipharma GmbH, 6250 Limburg |
"arzneimittel"
|
|
US4510322A
(en)
|
1981-07-13 |
1985-04-09 |
Merck & Co., Inc. |
Indacrinone having enhanced uricosuric
|
|
DE3232922A1
(de)
|
1982-09-04 |
1984-03-08 |
Hoechst Ag, 6230 Frankfurt |
Sulfamoylbenzophenon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
|
|
US4632930A
(en)
|
1984-11-30 |
1986-12-30 |
E. I. Du Pont De Nemours And Company |
Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
|
|
JPH0366669A
(ja)
|
1989-08-03 |
1991-03-22 |
Shionogi & Co Ltd |
複素環式化合物
|
|
ES2092580T3
(es)
|
1990-11-30 |
1996-12-01 |
Teijin Ltd |
Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo.
|
|
CA2115442C
(en)
|
1991-09-09 |
2003-09-23 |
Christopher Franklin Bigge |
Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist
|
|
US5358961A
(en)
|
1991-11-30 |
1994-10-25 |
Jin Ro Limited |
Pyrrolidine derivatives
|
|
SE9301830D0
(sv)
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
|
JPH07242694A
(ja)
|
1994-02-28 |
1995-09-19 |
Yamasa Shoyu Co Ltd |
トリアゾロプリンヌクレオシド誘導体及び該誘導体を製造するのに有用な合成中間体
|
|
US5514681A
(en)
|
1994-08-17 |
1996-05-07 |
Virginia Tech Intellectual Properties, Inc. |
Compositions and methods for controlling pest insects
|
|
US5770601A
(en)
|
1994-08-17 |
1998-06-23 |
Virginia Tech Intellectual Properties, Inc. |
Compositions and methods for controlling pest insects
|
|
US6037344A
(en)
|
1994-08-17 |
2000-03-14 |
Virginia Tech Intellectual Properties, Inc. |
Compositions and methods for controlling pest insects
|
|
AUPM835394A0
(en)
|
1994-09-23 |
1994-10-13 |
King, Michael G. Dr. |
Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
|
|
US5990118A
(en)
|
1995-02-21 |
1999-11-23 |
Yamasa Corporation |
Purine compounds and xanthine oxidase inhibitors
|
|
US6084147A
(en)
|
1995-03-17 |
2000-07-04 |
Studsvik, Inc. |
Pyrolytic decomposition of organic wastes
|
|
DE69632854T2
(de)
|
1995-04-07 |
2005-07-14 |
Teijin Ltd. |
Schutzmittel für Organe und Gewebe
|
|
ID21775A
(id)
|
1996-10-25 |
1999-07-22 |
Yoshitomi Pharmaceutical |
Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
|
|
US5965625A
(en)
*
|
1997-03-21 |
1999-10-12 |
King; Michael Glenn |
Compositions and methods for the control of smoking
|
|
AU1520699A
(en)
|
1997-11-07 |
1999-05-31 |
Johns Hopkins University, The |
Methods for treatment of disorders of cardiac contractility
|
|
JPH11140086A
(ja)
|
1997-11-07 |
1999-05-25 |
Yamasa Shoyu Co Ltd |
４−置換−１Ｈ−６−オキソピラゾロ［３，４−ｄ］ピリミジン化合物及びキサンチンオキシダーゼ阻害剤
|
|
CA2566652C
(en)
|
1998-06-19 |
2008-10-21 |
Teijin Limited |
Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
|
|
RU2246318C2
(ru)
|
1998-08-06 |
2005-02-20 |
Маунтэн Вью Фармасьютикэлз, Инк. |
Конъюгаты peg-уриказы и их использование
|
|
GB9824310D0
(en)
|
1998-11-05 |
1998-12-30 |
Univ London |
Activators of soluble guanylate cyclase
|
|
US6281222B1
(en)
|
1999-08-19 |
2001-08-28 |
Inotek Corporation |
Compositions and method for treatment of acetaminophen intoxication
|
|
EP1317258B1
(en)
|
2000-06-28 |
2009-02-11 |
Merck & Co., Inc. |
Use of allopurinol for the treatment of hypertension
|
|
JP2002105067A
(ja)
*
|
2000-09-28 |
2002-04-10 |
Teijin Ltd |
２−フェニルチアゾール誘導体、およびそれを有効成分とする医薬組成物
|
|
ITMI20010206A1
(it)
|
2001-02-02 |
2002-08-02 |
Dompe Spa |
Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
|
|
WO2002085380A1
(en)
|
2001-04-18 |
2002-10-31 |
Geltex Pharmaceuticals, Inc. |
Method for treating gout and reducing serum uric acid
|
|
WO2002085381A1
(en)
|
2001-04-18 |
2002-10-31 |
Genzyme Corporation |
Method for treating gout and binding uric acid
|
|
JP2005507932A
(ja)
|
2001-10-12 |
2005-03-24 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのフェニル置換５−員窒素含有複素環
|
|
CA2462132C
(en)
|
2002-01-28 |
2010-08-10 |
Fuji Yakuhin Co., Ltd. |
1,2,4-triazole compounds
|
|
US20060040945A1
(en)
|
2002-05-17 |
2006-02-23 |
Merckle Gmbh |
Annellated pyrrole compounds as proton pump inhibitors for treating ulcer
|
|
US7078423B2
(en)
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
|
US20040121004A1
(en)
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
US20040122067A1
(en)
|
2002-12-20 |
2004-06-24 |
Lin Zhao |
Treatment of chronic heart failure
|
|
US20040131676A1
(en)
|
2002-12-20 |
2004-07-08 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
WO2005018635A2
(en)
|
2003-08-07 |
2005-03-03 |
Cardiome Pharma Corp. |
Ion channel modulating activity i
|
|
WO2006028342A1
(en)
|
2004-09-06 |
2006-03-16 |
Biosynergen, Inc. |
A novel xanthine oxidase inhibitor and a pharmaceutical composition containing the same
|
|
WO2006055412A1
(en)
|
2004-11-19 |
2006-05-26 |
Shiva Biomedical, Llc |
Methods of treating erythropoietin-resistance
|
|
CA2607953A1
(en)
*
|
2005-05-09 |
2006-11-16 |
Tap Pharmaceutical Products, Inc. |
Methods for treating nephrolithiasis
|
|
EP1940397A4
(en)
|
2005-08-03 |
2010-01-20 |
Takeda Pharmaceuticals North A |
METHOD FOR TREATING HYPERTONIA
|
|
US20090124623A1
(en)
|
2006-11-13 |
2009-05-14 |
Christopher Lademacher |
Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
|
|
EP2101761A4
(en)
|
2006-11-13 |
2010-01-27 |
Takeda Pharmaceuticals North A |
METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS
|
|
CN101646440A
(zh)
|
2007-01-19 |
2010-02-10 |
武田制药北美公司 |
使用黄嘌呤氧化还原酶抑制剂和抗炎剂预防痛风突发或减少痛风突发次数的方法
|
|
MX2007011927A
(es)
|
2007-09-26 |
2009-03-26 |
World Trade Imp Export Wtie Ag |
Composiciones farmaceuticas que comprenden la combinacion de un agente antiinflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas.
|
|
US20100311756A1
(en)
|
2009-01-22 |
2010-12-09 |
Takeda Pharmaceuticals North America, Inc. |
Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
|
|
AU2011299153B2
(en)
|
2010-09-10 |
2014-10-30 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for concomitant treatment of theophylline and febuxostat
|